Feizhe Xiao
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Immunology
- Pathology and Forensic Medicine top 10%
- Oncology
- Topics
- Circular RNAs in diseases (12 papers)Cancer-related molecular mechanisms research (10 papers)MicroRNA in disease regulation (6 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Feizhe Xiao
17 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Molecular Biology 3.0k
- Cancer Research 2.5k
- Immunology 148
- Pathology and Forensic Medicine 130
- Oncology 126
Countries citing papers authored by Feizhe Xiao
This map shows the geographic impact of Feizhe Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feizhe Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feizhe Xiao more than expected).
Fields of papers citing papers by Feizhe Xiao
This network shows the impact of papers produced by Feizhe Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feizhe Xiao. The network helps show where Feizhe Xiao may publish in the future.
Co-authorship network of co-authors of Feizhe Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Feizhe Xiao. A scholar is included among the top collaborators of Feizhe Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feizhe Xiao. Feizhe Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 39 | |
| 2 | 16 | |
| 3 | 44 | |
| 4 | 17 | |
| 5 | 53 | |
| 6 | 40 | |
| 7 | 10 | |
| 8 | 58 | |
| 9 | 125 | |
| 10 | Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signallingbreakdown → | 262 |
| 11 | 125 | |
| 12 | 90 | |
| 13 | 0 | |
| 14 | 256 | |
| 15 | A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesisbreakdown → | 585 |
| 16 | A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastomabreakdown → | 548 |
| 17 | Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesisbreakdown → | 859 |
| 18 | 98 |
About Feizhe Xiao
Feizhe Xiao is a scholar working on Cancer Research, Molecular Biology and Neurology, having authored 18 papers that have together received 3.2k indexed citations. Recurring topics across this work include Circular RNAs in diseases (12 papers), Cancer-related molecular mechanisms research (10 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (3.0k citations) and Pathology and Forensic Medicine (130 citations). Feizhe Xiao has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Nu Zhang, Maolei Zhang, Huangkai Zhou, Xuesong Yang, Nunu Huang, Kun Zhao, Sheng Yan, Xinya Gao, Suyun Huang and Bo Xie. Their work appears in journals such as Nature Communications, Nature Cell Biology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.